Fundraising FoxArTara Therapeutics
New York, US · Founded 2017 · Delaware corporation
Find your way into ArTara Therapeutics
Sign up to see every warm intro you have to ArTara Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ArTara Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
DS
David SmithExecutive
RM
Randall MarshallExecutive
JS
Jesse SheffermanNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$4.2M disclosed across 1 round · 2017
▶$4.2MraisedJan 2018 · 2 investors · PharmaceuticalsRule 506(b)
▶$4.2MraisedJan 2018 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- David SmithExecutive Officer
- Jesse SheffermanExecutive Officer, Director
- Randall MarshallExecutive Officer, Director
- Amount sold
- $4.2M
- Minimum investment
- $25K
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has ArTara Therapeutics raised?
- ArTara Therapeutics has disclosed $4.2M raised across 1 round.
- Where is ArTara Therapeutics headquartered?
- ArTara Therapeutics is headquartered in New York, US.